Varian Medical Systems

Rank: 27
2016 Rank31
R&D Spend:$253,500,000
Fiscal year ending:09-30-16
Click here to see all 100

Varian Honored Among World's 100 Most Sustainable Corporations 2015

Varian Selected to Provide Planning Software for New UK Proton Therapy Center.

Big 100 Mini Logo Key Personnel: Dow Wilson, president & CEO; Jessica Denecour, EVP & CIO; Gary Bischoping Jr., SVP & CFO; Kolleen Kennedy, EVP, oncology systems; Patrick Joda, SVP, global operations; Moataz Karmalawy, VP and general manager, worldwide particle therapy; Dr. Deepak “Dee” Khuntia, SVP and CMO; John Kuo, SVP, general counsel and corporate secretary; Magnus Momsen, SVP and corporate controller; Franco Palomba, SVP, finance and treasurer; Wendy Scott, SVP and chief human resources officer; Rafael Torres, SVP, business development and strategy; Chris Toth, chairman, global commercial & field operations; Vy H. Tran, SVP, regulatory affairs and quality assurance; Corey Zankowski, SVP, CTO; Andrew Whitman, SVP, government affairs;

Palo Alto, California